Navigation Links
Children's Hospital 1 of 10 pediatric hospitals in US selected to study liver disease in kids
Date:2/26/2008

Childrens Hospital of Pittsburgh of UPMC has been selected to join an effort among select centers in the United States and Canada to collect and study information necessary to understand the possible causes and treatment of a destructive liver disease called primary sclerosing cholangitis (PSC).

The Studies of Primary Sclerosing Cholangitis, or STOPSC, is a multi-center research effort initiated, funded and organized by The Musette and Allen Morgan Jr. Foundation. PSC is a destructive liver disease of unknown origin that occurs in both males and females and in children and adults. About one person in every 100,000 will get the disease, and currently there is no proven medical treatment for PSC.

Researchers across the country will establish a database and specimen storehouse in an effort to make the information available to other qualified researchers so future studies can be conducted. The major goal of this study is to help develop better ways to detect the disease, find out how effective current treatments are, and conduct more research studies in the future.

This effort is so important for many reasons most important is to better understand the disease and how to treat it. By combining all of our information and research, together, we can tackle this devastating disease head on, said Benjamin L. Shneider, MD, director of the Pediatric Hepatology Program at Childrens Hospital, who is a member of the American Association for the Study of Liver Diseases. At Childrens Hospital of Pittsburgh of UPMC, we are dedicated to helping children with liver disease by exploring all treatment options maximizing liver function, minimizing complications and maintaining growth and development all to improve the quality of life for each child and family.

The study also will include adults and children with a diagnosis of PSC/autoimmune hepatitis (AIH) overlap syndrome and children diagnosed with AIH, because the clinical aspects and the possible causes of these diseases may be related. AIH is usually quite serious and, if not treated, gets worse over time. Its usually chronic, meaning it can last for years, and can lead to cirrhosis (scarring and hardening) of the liver and eventually liver failure. In addition, many individuals with PSC will also get inflammatory bowel disease.

Childrens is one of only 10 pediatric hospitals selected to participate in this national study. Other hospitals include the Mayo Clinic, Childrens Hospital of Denver, Childrens Hospital Boston, and Mount Sinai Medical Center, to name a few.


'/>"/>

Contact: Marc Lukasiak
marc.lukasiak@chp.edu
412-692-7919
Children's Hospital of Pittsburgh
Source:Eurekalert

Related medicine news :

1. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
2. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
3. Hidden Epidemic of Congestive Heart Failure Driving Hospitalization, Costs
4. Galichia Heart Hospital Lowers Cost of Bypass to $10K
5. Expansion Will Double Size of The Heart Center at Regions Hospital
6. Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens
7. Ten Hospitals Now Complete with KP HealthConnect Electronic Medical Records
8. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
9. TexSAn Heart Hospital Signs Agreement with Blue Cross and Blue Shield of Texas
10. Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0
11. Northwestern Memorial Hospitals Steven J. Stryker MD Unveils Campaign With Empower Public Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: